BYSL (Bystin Like, 6p21.1), a direct cMYC target24, is required for nucleologenesis in HCC cell proliferation and its inhibition induces apoptosis, partially arrests the cell cycle and inhibits tumor formation in mouse xenografts25. Here, MYC is linked to hepatocellular carcinoma.